10x Genomics builds solutions to interrogate biological systems at a resolution and scale that matches the complexity of biology. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com

ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics and transcriptomics, including precise stitching, registration, segmentation and statistical analyses of cellular neighbourhoods. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.

Canopy Biosciences, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our proprietary technology ChipCytometry™ is a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with our CLIA-certified laboratory, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at CanopyBiosciences.com.

Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.

Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.

Widely recognized for optical precision and innovative technology, Leica Microsystems is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy with related imaging systems, electron microscopy sample preparation, and surgical microscopy. Product Portfolio Users of Leica Microsystems´ instruments and services can be found in both clinical and life science research, several surgical specializations, disciplines associated with material sciences, the manufacturing industry, and forensics services as well as in classrooms around the world. Instruments and workflow solutions for electron microscopy sample preparation for life sciences and industrial applications alike complete the company´s product portfolio

Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.

MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and life course equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. As of June 30, 2023, MGI has more than 2,800 employees, and 35.2% of whom are R&D personnel. Founded in 2016, MGI operates in more than 90 countries and regions, serving more than 2,400 customers. It has established scientific research and production bases, global training and service network in many countries and regions around the world. MGI is one of the few companies in the world that can independently develop and mass-produce low-, medium- and high-throughput clinical gene sequencers from GB to TB. Providing real-time, comprehensive, life course solutions, its vision is to lead life science innovation.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions. The GeoMx® Digital Spatial Profiler is a flexible solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMx™ Spatial Molecular Imager (SMI) is an FFPE-compatible, single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments. The AtoMx™ Spatial Informatics Platform (SIP) is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling spatial biology insights anytime, anywhere. www.nanostring.com.

Pixelgen Technologies is at the forefront of innovative life science research tools. Pixelgen located in Stockholm Sweden, was founded in 2020 on the principle that understanding how proteins move and relocate across the cell membrane is critical to better understanding cell activity. The company has developed a foundational IP portfolio around its Molecular Pixelation (MPX™) technology, which is the first high-resolution technology to capture the dynamic changes occurring in the cell surface proteome to such high-multiplex levels on thousands of single cells simultaneously. The Molecular Pixelation workflow connects antibody-based technologies and next generation sequencing to generate unprecedented resolution of protein activity and mobility. The first reagent kit product was launched last year, targeting the surface proteome of immune cells, enabling measurements of 76 target proteins and four controls in 3D without the use of a microscope. The MPX reagent kit is built on DNA sequence formation providing target identity, abundance and spatial location such as protein polarization and co-localization. Subcellular resolution is produced utilizing standard instrumentation for sequencing already present in most labs, thus allowing for barrier-free adoption for any researcher. Molecular Pixelation is used by our customers to enable spatial proteomics of single cells gaining new insights into cellular activity and drug development. www.pixelgen.com

RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.

Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.

Through ultrasensitive InSituPlex® assays and advanced, AI-driven spatial analysis, Ultivue empowers scientists developing precision cancer therapies to generate quantitative, high confidence insights in just a fraction of the time.

Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single-cell spatial genomics, setting the standard for the spatial genomics field. The company’s MERSCOPE® Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution. Powered by the proven MERFISH (Multiplexed error robust fluorescence in situ hybridization) technology, over 180 publications demonstrate how the technology is enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context. The MERSCOPE® Platform provides transformative insight into a wide range of tissue-scale basic research and translational medicine in oncology, immunology, neuroscience, infectious disease, developmental biology, cell and gene therapy, and is an essential tool for accelerating drug discovery and development. For more information, go to www.vizgen.com. Connect on social media Twitter, LinkedIn and Facebook.